The most common side effects include nausea, vomiting, diarrhea, pain, and constipation, which are typical digestive system symptoms reported
2.1.5 Ritlecitinib Ritlecitinib is an oral selective JAK3/TEC family kinase inhibitor studied in the VIBRATO trial (NCT02958865), a Phase 2b double-blind placebo-controlled RCT umbrella study that evaluated its efficacy in moderate-to-severe UC patients aged 1875 years with a total MS 6, RBS 1, and MES 2
They also tend to be low in fiber, which means they do not help you feel full
Check-ins fit my schedule
Available from: Qiu J, Lundberg PW, Javier Birriel T, et al
Importantly, reviewers describe the brand tone as "technical but approachable," avoiding hype while still making the compound accessible for those in educational or pharmaceutical research settings